Long-term care homes the priority for Ottawa's limited COVID-19 vaccine supply

Long-term care homes the priority for Ottawa's limited COVID-19 vaccine supply

Von der Leyen said the immediate challenge would be securing enough doses to make sure people who already had their first shot of Pfizer vaccine received their second jab within the recommended interval.

The health ministry said yesterday it increased its order of Pfizer Inc's COVID-19 vaccine, which is expected to be approved next month.

Pfizer and BioNTech say that they are encouraged by these early in vitro study findings.

Pfizer has temporarily cut vaccine deliveries to Canada due to expansion plans at its European manufacturing facility. Vaccine doses administered is not equivalent to the number of people inoculated as the approved vaccines require two doses per person.

The Therapeutic Goods Administration says it's working with European regulators to determine whether specific warnings about risks of vaccination in the very frail elderly or terminally ill should be applied to the Pfizer vaccine.

However, the study concluded that monoclonal antibody therapies now in use should be tested against the new variants and that mRNA vaccines may need to be updated "periodically to avoid potential loss of clinical efficacy".

The Czech government was bracing for the disruption to last weeks, slowing its vaccination campaign just as the second dose of vaccinations get under way.

Despite concerns over the new vaccine in combating the COVID-19 pandemic, a medical expert opines that the vaccine is the best solution in dealing with the outbreak which has no other specific treatment so far.

More than 2 million Israelis had received the first dose of the vaccine. "The goal is to secure additional doses going forward so that we can meet the demand as per the provincial guidelines".

Major General Dany Fortin, who's co-ordinating the COVID-19 vaccine rollout, said Canada's shipments of the vaccine will be cut by almost one-fifth this week and then will go down to zero next week.

The roll out of vaccines is seen as the light at the end of the tunnel of the COVID-19 crisis, but like any major event it's also an opportunity for scammers and cybercriminals.

Frustration is mounting from Europe to North America over reduced shipments of Pfizer's COVID-19 vaccine while the U.S. pharmaceutical company increases production capacity at its Belgian plant.

Related Articles